The present disclosure relates generally to a negative pressure wound therapy (NPWT) device. The present disclosure relates more specifically to protecting a NPWT device from fluid ingress.
Negative pressure wound therapy (NPWT) involves applying negative pressure (relative to atmospheric pressure) to a wound site to promote healing. Typically, a wound dressing is sealed over a wound bed and air is pumped out of the dressing to create a negative pressure at the wound bed. In some NPWT systems, fluid is pumped out of the dressing or instilled into the dressing while negative pressure is applied to the wound site.
Wounds are known to produce fluid at the wound site. NPWT is also known facilitate fluid exudation from wound sites and can subsequently draw fluid in in the direction of a NPWT device. NPWT devices can be damaged and/or contaminated by contact with such fluids. Commonly, tubing for NPWT systems is manipulated due to movement of a patient, with high-profile fluid ingress protection systems easily damaged, disrupted, or displaced due to said manipulation. As such, it is desirable to provide cost-efficient and disposable low-profile fluid ingress protection between the wound site and the NPWT device so as to prevent fluid ingress from the wound site to the NPWT device and maintain functionality through normal patient movement patterns.
At least one embodiment relates to a negative pressure wound therapy (NPWT) system including a NWPT therapy unit and a wound dressing configured to overlay a wound bed. The NPWT system also includes a first length of tubing having a first end and a second end, with the first end of the first length of tubing coupled to the NPWT therapy unit and the second end of the first length of tubing having a first coupling half. The NPWT system also includes a second length of tubing having a first end and second end, with the first end of the second length of tubing coupled to the wound dressing and the second end of the second length of tubing having a second coupling half. Additionally, the NPWT system includes an inline filter including a sintered polymer and a superabsorbent material and an inline coupling, with the inline coupling comprising a first coupling half and a second coupling half, wherein the inline coupling is configured to operably couple and de-couple the NPWT therapy unit to the wound dressing.
Another embodiment relates to a NPWT system wherein the filter includes a mixture of polyethylene and a super absorbing polymer, and is configured to perform as a gel-block when wet so as to prevent fluid from migrating through the filter.
Another embodiment relates to a NPWT system wherein the first coupling half comprises a female connector and the second coupling half comprises a male connector.
Another embodiment relates to a NPWT system wherein the wherein the inline filter is disposed within the inline coupling.
Another embodiment relates to a NPWT system wherein the filter is disposed within the second coupling half.
Another embodiment relates to a NPWT system wherein the inline filter further comprises a dye configured to be released when wet so as to indicate exposure of the inline filter to fluid.
Another embodiment relates to a NPWT system wherein the filter further comprises activated charcoal as a mixture or a layer.
At least one embodiment relates to a dressing assembly, with the dressing assembly including a wound dressing configured to overlay a wound bed, a length of tubing coupled to the wound dressing, and a filter including a sintered polymer and a superabsorbent material disposed within the tubing.
Another embodiment relates to a dressing assembly wherein the filter comprises a mixture of polyethylene and a super absorbing polymer, and is configured to perform as a gel-block when wet so as to prevent fluid from migrating through the filter.
Another embodiment relates to a dressing assembly including an inline coupling disposed within the tubing, with the filter disposed within the coupling.
Another embodiment relates to a dressing assembly wherein the coupling comprises a first half and a second half and the filter is disposed within either the first half or the second half.
Another embodiment relates to a dressing assembly wherein the first half of the coupling comprises a female component and the second half of the coupling comprises a male component.
Another embodiment relates to a dressing assembly wherein the filter comprises a dye configured to be released when wet so as to indicate exposure of the filter to fluid.
Another embodiment relates to a dressing assembly wherein the filter comprises activated charcoal as a mixture or a layer, the activated charcoal configured to improve absorbency of the filter as well as reduce dressing odor.
At least one embodiment relates to a filter and tubing assembly for a NPWT dressing with the filter and tubing assembly including a first length of tubing, with the first length of tubing including a first end configured to be coupled to a therapy unit, and a second end comprising a first coupling half. The filter and tubing assembly also includes a second length of tubing including a first end configured to be coupled to a wound dressing and a second end comprising a second coupling half, wherein the second coupling half is configured to mate via a mating interface with the first coupling half, as well as a filter including a sintered polymer and a superabsorbent material, the filter disposed within the second length of tubing or the second coupling half.
Another embodiment relates to a filter and tubing assembly for a NPWT dressing wherein the filter comprises a mixture of polyethylene and a super absorbing polymer, and is configured to perform as a gel-block when wet so as to prevent fluid from migrating through the filter.
Another embodiment relates to a filter and tubing assembly for a NPWT dressing wherein the first coupling half comprises a female component and the second coupling half comprises a male component.
Another embodiment relates to a filter and tubing assembly for a NPWT dressing wherein the filter comprises a dye configured to be released when wet so as to indicate exposure of the filter to fluid.
Another embodiment relates to a filter and tubing assembly for a NPWT dressing wherein the filter comprises activated charcoal as a mixture or a layer.
At least one embodiment relates to a method of making a wound dressing including providing a wound interface layer configured to overlay a wound bed, providing an absorbent layer over the wound interface layer and a drape with the drape positioned over the absorbent layer, and attaching a low-pressure interface on the drape. The method of making a wound dressing further includes coupling a length of tubing having an inline connector to the low-pressure interface, and installing an inline filter including a sintered polymer and a superabsorbent material within the length of tubing or the inline connector.
Another embodiment relates to a method of making a wound dressing wherein the inline filter comprises a mixture of polyethylene and a super absorbing polymer, and is configured to perform as a gel-block when wet so as to prevent fluid from migrating through the inline filter.
Another embodiment relates to a method of making a wound dressing wherein the inline filter comprises activated charcoal as a mixture or a layer, the activated charcoal configured to improve absorbency of the inline filter as well as reduce dressing odor.
This summary is illustrative only and is not intended to be in any way limiting. Other aspects, inventive features, and advantages of the devices or processes described herein will become apparent in the detailed description set forth herein, taken in conjunction with the accompanying figures, wherein like reference numerals refer to like elements.
Before turning to the figures, which illustrate certain exemplary embodiments in detail, it should be understood that the present disclosure is not limited to the details or methodology set forth in the description or illustrated in the figures. It should also be understood that the terminology used herein is for the purpose of description only and should not be regarded as limiting.
Referring now to
Therapy device 102 includes a pump 110. Pump 110 is operable to pump air out of dressing 104 via tube 106 to create and maintain a negative pressure at wound bed 108. In some embodiments, pump 110 is electrically powered and therapy device 102 includes power systems and control circuitry to power and control operation of the pump 110. In some embodiments, pump 110 is manually-powered, such that a user may manipulate pump 110 to draw air out of dressing 104 as desired by the user. For example, pump 110 may be spring-loaded to gradually pull air from dressing 104 for a duration of time following a compression of pump 110 by the user.
NPWT system 100 shown in
Referring now to
First tubing 212 is shown to include a first end 214 and second end 216. First end 214 of first tubing 212 is coupled to therapy unit 202 such that an airtight seal is formed. First end 214 of first tubing 212 may include one or more retention mechanisms configured to facilitate coupling and airtight sealing with therapy unit 202 which is to say that therapy unit 202 may have complimentary retaining components. Second end 216 of first tubing 212 is configured opposite first end 214. Second end 216 of first tubing 212 is coupled to an inline coupling 224. Inline coupling 224 includes a first coupling portion 226 and a second coupling portion 228, with first coupling portion 226 configured to receive second end 216 of first tubing 212, with first coupling portion 226 and inline coupling 224 forming an airtight seal with second end 216 of first tubing 212. In some embodiments, first end 214 of first tubing 212 may include one or more coupling and/or retention mechanisms. Inline coupling 224 is configured to retain second end 216 of first tubing 212 there within and form an airtight seal with second end 216 of first tubing 212. Inline coupling 224 and/or first coupling portion 226 may include one or more retaining mechanisms configured to mate with second end 216 of first tubing 212 in order to facilitate coupling and said airtight sealing, for example threading, protrusions, or recesses complimentary to components of second end 216 of first tubing 212. First tubing 212 may vary in length and/or diameter in order to accommodate different models of therapy unit 210 and provide different forms of treatment to a patient.
Second coupling portion 228 is configured opposite inline coupling 224 from first coupling portion 226. Second coupling portion is configured to receive a first end 220 of a second tubing 218 as shown in the exemplary embodiment of
In some embodiments, a filter may be configured within one or more of second end 216 of first tubing 212, inline coupling 224, first coupling portion 226, second coupling portion 228, and first end 220 of second tubing 218. The filter may include dimensions that ensure a secure fit within one or more of the previously mentioned components, and may be inserted therein. Additionally, the filter may be configured to allow airflow therethrough when dry, but perform a “gel-block” upon coming in contact with fluid thus restricting or preventing fluid from moving beyond the filter. “Gel-block” is intended to refer to polymeric materials configured to absorb fluid and increase in volume, with the increase in volume effectively blocking a tubing and preventing further movement of fluid.
Second tubing 218 further includes a second end 222, with second end 222 configured opposite second tubing 218 from first end 220. Second end 222 of second tubing 218 is configured to couple with a portion of a wound dressing such as dressing 104 of
Referring now to
The system for fluid ingress protection includes second tubing 218 (as shown in
In coupling with an additional component, second coupling portion 228 is configured to interface with said additional component. In some embodiments, second coupling portion 228 may be received by the additional component with retaining mechanism 326 mating with a complimentary retaining mechanism thereof. Second coupling portion 228 may be configured to abut any additional component. Second coupling portion 228 is further configured to promote the formation of an airtight seal between the system of
The system of
According to one embodiment filter 330 is hydrophobic and comprises a sintered polymer polythene, which incorporates (or is impregnated with) a gelling agent to ensure the formation of a complete seal upon contact with fluid. Filter 330 may further comprise a mixture of polythene and a super absorbing polymer (SAP) and/or other superabsorbent materials or materials with superabsorbent properties. In some embodiments, filter 330 may comprise a Porex material, for example part number XS-5070 or XM-1777. Filter 330 may also comprise a dye, with the dye configured to be released upon contact with fluid within second tubing 218 for example, to indicate to healthcare providers the presence of fluid in contact with filter 330. Filter 330 may further comprise activated charcoal, which may be configured as a coating, a layer of, or added to the mixture of filter 330 so as to reduce dressing odor when dry. Such an addition of activated charcoal may also improve absorbency of filter 330 and thus fluid blocking/sealing ability, as well as increasing breakthrough pressure of filter 330. Filter 330 may be generally configured to absorb small amounts of fluid after contact while simultaneously blocking larger amounts of fluid from migrating past or through filter 330. In some embodiments, absorbency of filter 330 may recover after contact with a fluid.
In some embodiments, filter 330 may include a length ranging from approximately 2 mm to 8 mm as well as a diameter ranging from approximately 3 mm to 5 mm. It should be noted that filter 330 can be configured according to second tubing 218 and any geometry and/or dimensions thereof in order to from a tight interference fit once placed. In alternative embodiments, filter 330 may further include combinations of porous polymer material of approximately 250 microns and 7 mm of, for example Luquasorb absorbent granules, within tubing such as second tubing 218 in order to maintain airflow while providing fluid blockage upon contact with any fluid. Some other embodiments may include the aforementioned porous polymer material decreased to approximately 1 mm. In some embodiments, filter 330 may include an average pore size ranging from approximately 20-60 micrometers with one side of a given sheet rough and one side of a given sheet smooth. Other properties of filter 330 may include accommodating an airflow ranging from approximately 160-480 ml/min at a set inlet pressure of approximately 1.2″ water with test disc measurement of approximately 19 mm (e.g., PA 02-07), a target density ranging from approximately 0.51-0.59 g/cm3, a tensile strength greater than approximately 1.3 N/mm2, and an embedded contamination no greater than approximately 1.6 mm. Additionally, surface imperfection excluding embedded contamination may not exceed approximately 5% of surface area. Possible materials of filter 330 also may not have guaranteed air distribution. Filter 330 may further comprise polytetrafluoroethylene (PTFE). Filter 330, in various configurations and different embodiments, may also be applicable or adapted for use in other applications in which a risk of fluid ingress may be detrimental to a device.
In some embodiments, filter 330 may be disposed within a coupling component separate from and/or adjacent to a piece of tubing such as second tubing 218, for example a male component of a coupling mechanism. Filter 330 may also be configured on a dressing-side (not shown, but similar to that of
Referring now to
Referring now to
As utilized herein, the terms “approximately,” “about,” “substantially”, and similar terms are intended to have a broad meaning in harmony with the common and accepted usage by those of ordinary skill in the art to which the subject matter of this disclosure pertains. It should be understood by those of skill in the art who review this disclosure that these terms are intended to allow a description of certain features described and claimed without restricting the scope of these features to the precise numerical ranges provided. Accordingly, these terms should be interpreted as indicating that insubstantial or inconsequential modifications or alterations of the subject matter described and claimed are considered to be within the scope of the disclosure as recited in the appended claims.
It should be noted that the term “exemplary” and variations thereof, as used herein to describe various embodiments, are intended to indicate that such embodiments are possible examples, representations, or illustrations of possible embodiments (and such terms are not intended to connote that such embodiments are necessarily extraordinary or superlative examples).
The term “coupled” and variations thereof, as used herein, means the joining of two members directly or indirectly to one another. Such joining may be stationary (e.g., permanent or fixed) or moveable (e.g., removable or releasable). Such joining may be achieved with the two members coupled directly to each other, with the two members coupled to each other using a separate intervening member and any additional intermediate members coupled with one another, or with the two members coupled to each other using an intervening member that is integrally formed as a single unitary body with one of the two members. If “coupled” or variations thereof are modified by an additional term (e.g., directly coupled), the generic definition of “coupled” provided above is modified by the plain language meaning of the additional term (e.g., “directly coupled” means the joining of two members without any separate intervening member), resulting in a narrower definition than the generic definition of “coupled” provided above. Such coupling may be mechanical, electrical, or fluidic.
It is important to note that the construction and arrangement of the [apparatus, system, assembly, etc.] as shown in the various exemplary embodiments is illustrative only. Additionally, any element disclosed in one embodiment may be incorporated or utilized with any other embodiment disclosed herein. For example, the filter 330 of the exemplary embodiment described in at least paragraph(s) [0044]-[0047] may be incorporated in the NPWT system of the exemplary embodiment described in at least paragraph(s) [0036]. Although only one example of an element from one embodiment that can be incorporated or utilized in another embodiment has been described above, it should be appreciated that other elements of the various embodiments may be incorporated or utilized with any of the other embodiments disclosed herein.
This application claims the benefit of priority to U.S. Provisional Application No. 62/848,380, filed on May 15, 2019, and U.S. Provisional Application No. 62/732,220, filed on Sep. 17, 2018, which are each incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
1355846 | Rannells | Oct 1920 | A |
2547758 | Keeling | Apr 1951 | A |
2632443 | Lesher | Mar 1953 | A |
2682873 | Evans et al. | Jul 1954 | A |
2910763 | Lauterbach | Nov 1959 | A |
2969057 | Simmons | Jan 1961 | A |
3066672 | Crosby, Jr. et al. | Dec 1962 | A |
3367332 | Groves | Feb 1968 | A |
3520300 | Flower, Jr. | Jul 1970 | A |
3568675 | Harvey | Mar 1971 | A |
3648692 | Wheeler | Mar 1972 | A |
3682180 | McFarlane | Aug 1972 | A |
3826254 | Mellor | Jul 1974 | A |
4080970 | Miller | Mar 1978 | A |
4096853 | Weigand | Jun 1978 | A |
4139004 | Gonzalez, Jr. | Feb 1979 | A |
4165748 | Johnson | Aug 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4233969 | Lock et al. | Nov 1980 | A |
4245630 | Lloyd et al. | Jan 1981 | A |
4256109 | Nichols | Mar 1981 | A |
4261363 | Russo | Apr 1981 | A |
4275721 | Olson | Jun 1981 | A |
4284079 | Adair | Aug 1981 | A |
4297995 | Golub | Nov 1981 | A |
4333468 | Geist | Jun 1982 | A |
4373519 | Errede et al. | Feb 1983 | A |
4382441 | Svedman | May 1983 | A |
4392853 | Muto | Jul 1983 | A |
4392858 | George et al. | Jul 1983 | A |
4419097 | Rowland | Dec 1983 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4475909 | Eisenberg | Oct 1984 | A |
4480638 | Schmid | Nov 1984 | A |
4525166 | Leclerc | Jun 1985 | A |
4525374 | Vaillancourt | Jun 1985 | A |
4540412 | Van Overloop | Sep 1985 | A |
4543100 | Brodsky | Sep 1985 | A |
4548202 | Duncan | Oct 1985 | A |
4551139 | Plaas et al. | Nov 1985 | A |
4569348 | Hasslinger | Feb 1986 | A |
4605399 | Weston et al. | Aug 1986 | A |
4608041 | Nielsen | Aug 1986 | A |
4640688 | Hauser | Feb 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4664662 | Webster | May 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4733659 | Edenbaum et al. | Mar 1988 | A |
4743232 | Kruger | May 1988 | A |
4758220 | Sundblom et al. | Jul 1988 | A |
4787888 | Fox | Nov 1988 | A |
4826494 | Richmond et al. | May 1989 | A |
4838883 | Matsuura | Jun 1989 | A |
4840187 | Brazier | Jun 1989 | A |
4863449 | Therriault et al. | Sep 1989 | A |
4872450 | Austad | Oct 1989 | A |
4878901 | Sachse | Nov 1989 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4906233 | Moriuchi et al. | Mar 1990 | A |
4906240 | Reed et al. | Mar 1990 | A |
4919654 | Kalt | Apr 1990 | A |
4941882 | Ward et al. | Jul 1990 | A |
4953565 | Tachibana et al. | Sep 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4985019 | Michelson | Jan 1991 | A |
5037397 | Kalt et al. | Aug 1991 | A |
5086170 | Luheshi et al. | Feb 1992 | A |
5092858 | Benson et al. | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5134994 | Say | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5167613 | Karami et al. | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5215522 | Page et al. | Jun 1993 | A |
5232453 | Plass et al. | Aug 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5278100 | Doan et al. | Jan 1994 | A |
5279550 | Habib et al. | Jan 1994 | A |
5298015 | Komatsuzaki et al. | Mar 1994 | A |
5342376 | Ruff | Aug 1994 | A |
5344415 | DeBusk et al. | Sep 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5437622 | Carion | Aug 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5556375 | Ewall | Sep 1996 | A |
5607388 | Ewall | Mar 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
6071267 | Zamierowski | Jun 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6241747 | Ruff | Jun 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6488643 | Tumey et al. | Dec 2002 | B1 |
6493568 | Bell et al. | Dec 2002 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
8702665 | Locke | Apr 2014 | B2 |
9370731 | Mao | Jun 2016 | B2 |
9956325 | Malhi | May 2018 | B2 |
20020077661 | Saadat | Jun 2002 | A1 |
20020115951 | Norstrem et al. | Aug 2002 | A1 |
20020120185 | Johnson | Aug 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20090281526 | Kenny | Nov 2009 | A1 |
20100286638 | Malhi | Nov 2010 | A1 |
20110202022 | Walti | Aug 2011 | A1 |
20150051560 | Askem | Feb 2015 | A1 |
20150119830 | Luckemeyer | Apr 2015 | A1 |
20160339226 | Sealfon | Nov 2016 | A1 |
20170189236 | Locke | Jul 2017 | A1 |
20180071510 | Kunschak | Mar 2018 | A1 |
Number | Date | Country |
---|---|---|
550575 | Mar 1986 | AU |
745271 | Mar 2002 | AU |
755496 | Dec 2002 | AU |
2005436 | Jun 1990 | CA |
26 40 413 | Mar 1978 | DE |
43 06 478 | Sep 1994 | DE |
29 504 378 | Sep 1995 | DE |
0100148 | Feb 1984 | EP |
0117632 | Sep 1984 | EP |
0161865 | Nov 1985 | EP |
0358302 | Mar 1990 | EP |
1018967 | Jul 2000 | EP |
692578 | Jun 1953 | GB |
2 195 255 | Apr 1988 | GB |
2 197 789 | Jun 1988 | GB |
2 220 357 | Jan 1990 | GB |
2 235 877 | Mar 1991 | GB |
2 329 127 | Mar 1999 | GB |
2 333 965 | Aug 1999 | GB |
4129536 | Aug 2008 | JP |
71559 | Apr 2002 | SG |
8002182 | Oct 1980 | WO |
8704626 | Aug 1987 | WO |
90010424 | Sep 1990 | WO |
93009727 | May 1993 | WO |
94020041 | Sep 1994 | WO |
9605873 | Feb 1996 | WO |
9718007 | May 1997 | WO |
9913793 | Mar 1999 | WO |
WO-2011135287 | Nov 2011 | WO |
WO-2011135287 | Nov 2011 | WO |
Entry |
---|
Louis C. Argenta, MD and Michael J. Morykwas, PhD; Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience; Annals of Plastic Surgery; vol. 38, No. 6, Jun. 1997; pp. 563-576. |
Susan Mendez-Eatmen, RN; “When wounds Won't Heal” RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24. |
James H. Blackburn II, MD et al.: Negative-Pressure Dressings as a Bolster for Skin Grafts; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457; Lippincott Williams & Wilkins, Inc., Philidelphia, PA, USA. |
John Masters; “Reliable, Inexpensive and Simple Suction Dressings”; Letter to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK. |
S.E. Greer, et al. “The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin” British Journal of Plastic Surgery (2000), 53, pp. 484-487. |
George V. Letsou, MD., et al; “Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch”; Journal of Cardiovascular Surgery, 31, 1990, pp. 634-639. |
Orringer, Jay, et al; “Management of Wounds in Patients with Complex Enterocutaneous Fistulas”; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80. |
International Search Report for PCT International Application PCT/GB95/01983; dated Nov. 23, 1995. |
PCT International Search Report for PCT International Application PCT/GB98/02713; dated Jan. 8, 1999. |
PCT Written Opinion; PCT International Application PCT/GB98/02713; dated Jun. 8, 1999. |
PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; dated Jan. 15, 1998 & Apr. 29, 1997. |
PCT Written Opinion, PCT International Application PCT/GB96/02802; dated Sep. 3, 1997. |
Dattilo, Philip P., Jr., et al; “Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture”; Journal of Textile and Apparel, Technology and Management, vol. 2, Issue 2, Spring 2002, pp. 1-5. |
Kostyuchenok, B.M., et al; “Vacuum Treatment in the Surgical Management of Purulent Wounds”; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof. |
Davydov, Yu. A., et al; “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof. |
Yusupov. Yu.N., et al; “Active Wound Drainage”, Vestnki Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof. |
Davydov, Yu.A., et al; “Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds”; Vestnik Khirugi, Oct. 1988, pp. 48-52, and 8 page English translation thereof. |
Davydov, Yu.A., et al; “Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy”; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page English translation thereof. |
Chariker, Mark E., M.D., et al; “Effective Management of incisional and cutaneous fistulae with closed suction wound drainage”; Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. |
Egnell Minor, Instruction Book, First Edition, 300 7502, Feb. 1975, pp. 24. |
Egnell Minor: Addition to the Users Manual Concerning Overflow Protection—Concerns all Egnell Pumps, Feb. 3, 1983, pp. 2. |
Svedman, P.: “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 3, 1983, pp. 532-534. |
Chinn, Steven D. et al.: “Closed Wound Suction Drainage”, The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81. |
Arnljots, Björn et al.: “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scand J. Plast Reconstr. Surg., No. 19, 1985, pp. 211-213. |
Svedman, P.: “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Medical Science: Biomedical Technology, Clinical Medicine, Surgery and Transplantation, vol. 7, 1979, p. 221. |
Svedman, P. et al: “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous of Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
N.A. Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye Volkov et al. (Chuvashia State University, Cheboksary, U.S.S.R. 1986); pp. 94-96 (certified translation). |
K.F. Jeter, T.E. Tintle, and M. Chariker, “Managing Draining Wounds and Fistulae: New and Established Methods,” Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), pp. 240-246. |
G. {hacek over (Z)}ivadinovi?, V. ?uki?, {hacek over (Z)}. Maksimovi?, ?. Radak, and P. Pe{hacek over (s)}ka, “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Timok Medical Journal 11 (1986), pp. 161-164 (certified translation). |
F.E. Johnson, “An Improved Technique for Skin Graft Placement Using a Suction Drain,” Surgery, Gynecology, and Obstetrics 159 (1984), pp. 584-585. |
A.A. Safronov, Dissertation Abstract, Vacuum Therapy of Trophic Ulcers of the Lower Leg with Simultaneous Autoplasty of the Skin (Central Scientific Research Institute of Traumatology and Orthopedics, Moscow, U.S.S.R. 1967) (certified translation). |
M. Schein, R. Saadia, J.R. Jamieson, and G.A.G. Decker, “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery 73 (1986), pp. 369-370. |
D.E. Tribble, An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery 105 (1972) pp. 511-513. |
M.J. Morykwas, L.C. Argenta, E.I. Shelton-Brown, and W. McGuirt, “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation,” Annals of Plastic Surgery 38 (1997), pp. 553-562 (Morykwas I). |
C.E. Tennants, “The Use of Hypermia in the Postoperative Treatment of Lesions of the Extremities and Thorax,” Journal of the American Medical Association 64 (1915), pp. 1548-1549. |
Selections from W. Meyer and V. Schmieden, Bier's Hyperemic Treatment in Surgery, Medicine, and the Specialties: A Manual of Its Practical Application, (W.B. Saunders Co., Philadelphia, PA 1909), pp. 17-25, 44-64, 90-96, 167-170, and 210-211. |
V.A. Solovev et al., Guidelines, The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract, editor-in-chief Prov. V.I. Parahonyak (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1987) (“Solovev Guidelines”). |
V.A. Kuznetsov & N.a. Bagautdinov, “Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds,” in II All-Union Conference on Wounds and Wound Infections: Presentation Abstracts, edited by B.M. Kostyuchenok et al. (Moscow, U.S.S.R. Oct. 28-29, 1986) pp. 91-92 (“Bagautdinov II”). |
V.A. Solovev, Dissertation Abstract, Treatment and Prevention of Suture Failures after Gastric Resection (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1988) (“Solovev Abstract”). |
V.A.C.® Therapy Clinical Guidelines: A Reference Source for Clinicians; Jul. 2007. |
International Search Report and Written Opinion in International Application No. PCT/US2019/051101, dated Feb. 25, 2020. |
International Search Report and Written Opinion in International Application No. PCT/US2019/051113, dated Feb. 25, 2020. |
Number | Date | Country | |
---|---|---|---|
20200086015 A1 | Mar 2020 | US |
Number | Date | Country | |
---|---|---|---|
62848380 | May 2019 | US | |
62732220 | Sep 2018 | US |